T1	Pharmacokinetic_phenotype	0 42	Using plasma CBZ-diol / CBZ-epoxide ratios
T2	Pharmacokinetic_phenotype	45 68	diol / epoxide ratios )
T3	Phenotype	87 105	mEH activity , the
T4	Genomic_variation	121 156	diplotypes in each EPHX1 block were
T5	Pharmacokinetic_phenotype	169 193	CBZ-epoxide metabolism .
R1	isEquivalentTo	Arg1:T1	Arg2:T2
R2	isAssociatedWith	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T1	Arg2:T5
R5	isEquivalentTo	Arg1:T2	Arg2:T1
R6	isAssociatedWith	Arg1:T2	Arg2:T3
R7	isAssociatedWith	Arg1:T2	Arg2:T4
R8	influences	Arg1:T3	Arg2:T1
R9	influences	Arg1:T3	Arg2:T2
R10	influences	Arg1:T3	Arg2:T4
R11	influences	Arg1:T3	Arg2:T5
R12	influences	Arg1:T4	Arg2:T1
R13	influences	Arg1:T4	Arg2:T2
R14	influences	Arg1:T4	Arg2:T3
R15	influences	Arg1:T4	Arg2:T5
R16	isAssociatedWith	Arg1:T5	Arg2:T2
R17	isAssociatedWith	Arg1:T5	Arg2:T3
R18	isAssociatedWith	Arg1:T5	Arg2:T4
